BioPharma Cell & Gene Therapy Nexus

November 11th & 12th 2026

Crowne Plaza San Diego Mission Valley, CA

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

From Cells to Cures: Driving the Future of Medicine



The BioPharma Cell & Gene Therapy Nexus 2026 is a distinguished two-day global gathering dedicated to advancing the science, development, and application of cell and gene therapies. Designed to unite senior executives from pharmaceutical and biotechnology companies with select solution providers, the Nexus offers a highly focused environment that encourages strategic dialogue, peer-to-peer learning, and meaningful professional exchange, propelling the future of advanced therapies.

This conference provides an essential stage for unveiling groundbreaking research, showcasing transformative innovations, and sharing practical advancements across the field. Participation offers the chance to connect with thought leaders, gain actionable insights, and contribute to shaping the next chapter of cell and gene therapy.

Far more than a traditional meeting, the Nexus serves as a catalyst for collaboration. It strengthens critical partnerships, accelerates the translation of pioneering science into clinical practice, and brings together diverse stakeholders to drive innovation, disseminate expertise, and ultimately improve patient outcomes worldwide.

Agenda at a Glance

Cell Therapy

Cell Therapy

Unlock next-generation approaches in autologous and allogeneic cell therapy manufacturing, combining automation, decentralized production, and efficient scale-up strategies to drive cost efficiency and improve product consistency.

Gene Therapy

Gene Therapy

Enhance gene therapy manufacturing efficiency through advanced upstream and downstream solutions. Enable faster approvals with integrated analytics, optimized process control, and comprehensive characterization while ensuring product quality and consistency.

Breakthrough Speaking Sessions

Breakthrough Speaking Sessions

This is not a conventional tradeshow, it is a highly curated gathering designed to inspire meaningful exchange. Featuring an immersive program of keynote addresses, expert panels, interactive roundtables, and poster presentations, the event provides a dynamic environment for dialogue and discovery.

A Premium, All-Inclusive Experience

A Premium, All-Inclusive Experience

Every delegate at the Cell & Gene Therapy Nexus 2026 is treated as a VIP. From curated networking sessions to thoughtfully designed experiences, the Nexus fosters meaningful collaboration and personal comfort, creating the ideal environment for advancing dialogue, building partnerships, and driving progress in cell and gene therapy.

Master the Art of Seamless Conversation

Master the Art of Seamless Conversation

Network with top decision-makers and industry leaders in the cell and gene therapy space. Engage in meaningful one-to-one discussions, exchange valuable insights, explore innovative solutions, and build strategic partnerships that drive collaboration and future growth.

Unlock One-to-One Engagements

Unlock One-to-One Engagements

Connect with fellow delegates through dedicated one-to-one meetings designed to foster collaboration in cell and gene therapy. This flexible format enables you to explore strategic partnerships, exchange insights, and maximize every interaction, ensuring meaningful dialogue and impactful connections throughout the event.

Who Should Attend?

By Seniority Level
30%
43%
22%
5%
Top Management (C-Suite, Presidents)
Senior Management (VPs, Heads)
Middle Management (Directors, Managers)
Others
By Geographical
50%
25%
12%
10%
3%
West Coast, USA
East Coast, USA
Europe
Central USA
Others
  • Cell Biology & Stem Cell Research
  • Gene Editing & CRISPR Technologies
  • Viral Vector Development & Engineering
  • Non-Viral Delivery Systems
  • Immunology & Immune Cell Engineering
  • Translational Research & Clinical Development
  • Preclinical & Nonclinical Development
  • Manufacturing & Process Development
  • Analytical Development & Quality Control
  • Regulatory Science & Compliance in Advanced Therapies
  • Biomarker Discovery & Companion Diagnostics
  • Oncology Cell & Gene Therapy Innovation
  • Rare Disease Therapeutics Development
  • Nucleic Acid Therapeutics (DNA, RNA, mRNA)
  • Synthetic Biology & Advanced Therapeutic Platforms
  • Bioinformatics, AI/ML & Computational Biology
  • Modeling & Simulation for Therapy Development
  • CTGs & Clinical Trial Design & Operations
  • Patient Access & Commercialization Strategies
  • Safety, Toxicology & Risk Assessment in Gene Therapy
  • Commercialization & Reimbursement
  • Data Science & Digital Tools for Advanced Therapies

Our Invited Industry Leaders

Meet the Innovators Driving the Next Era of CGT

Daniel Oliver
Daniel Oliver

CEO and Founder

Rejuvenate Bio

LinkedIn
Dr. Judy Chou
Dr. Judy Chou

President, Chief Executive Officer, and Board Member

AltruBio Inc.

LinkedIn
Rick Sullivan
Rick Sullivan

Vice President of Delivery

Shape Therapeutics Inc.

LinkedIn
James Wabby, MTOPR
James Wabby, MTOPR

Vice President, Head of Regulatory Strategy

AbbVie

LinkedIn
Preet Chaudhary
Preet Chaudhary

Director, USC Blood and Marrow Transplant and Cell Therapy Program

University of Southern California

LinkedIn
Meena Narayanan, PhD
Meena Narayanan, PhD

Principal Scientist - CMC (ADQC - Analytical and Quality Control)

Genentech

LinkedIn
Zhuojin Xu
Zhuojin Xu

Associate Director, Head of Drug Product Sciences

Allogene Therapeutics

LinkedIn
Eric Schuur
Eric Schuur

Chief Executive Officer, Co-founder

HepaTx Corporation

LinkedIn
Pranav Mathur
Pranav Mathur

Director, Head of R&D

Cirsium Biosciences

LinkedIn
Stephanie Szobota, Ph.D.
Stephanie Szobota, Ph.D.

Director, Bioanalytical Science

Mahzi Therapeutics

LinkedIn
Dr. Ishani Dasgupta
Dr. Ishani Dasgupta

Senior Scientist

AbbVie

LinkedIn
Pete O'Heeron
Pete O'Heeron

Chairman/CEO/Founder

FibroBiologics

LinkedIn
Ed Johnson, MBA
Ed Johnson, MBA

CEO

Breath Biologics

LinkedIn
Mira Tohme
Mira Tohme

Associate Director/Principal Scientist, Translational Medicine

Nkarta, Inc.

LinkedIn
Chris Mason
Chris Mason

Director, Board of Directors

Papillon Therapeutics

LinkedIn
Pranav Sharma
Pranav Sharma

Founder & Chief Executive Officer

Xosomix

LinkedIn
Vered Caplan
Vered Caplan

CEO

Orgenesis

LinkedIn
Enayat Nikoopour
Enayat Nikoopour

Principal Scientist Translational Research

Precigen

LinkedIn
Jainu Jogani
Jainu Jogani

Founder and CEO

Child's Cure Genetic Research Foundation

LinkedIn
Akshata Ijantkar
Akshata Ijantkar

Senior Principal Scientist

Bristol Myers Squibb

LinkedIn
Ben Brimacombe
Ben Brimacombe

Founder

Exonic

LinkedIn
Maria-Daniela Cirnaru, PhD
Maria-Daniela Cirnaru, PhD

Director of Translational Neurobiology

BrainXell Therapeutics Global

LinkedIn
Nataraj Pagadala, Ph.D
Nataraj Pagadala, Ph.D

Founder, President & CEO

LigronBio Inc

LinkedIn
Dr. Abdulkader Rahmo
Dr. Abdulkader Rahmo

President & Chief Scientific Officer

SMSbiotech, Inc

LinkedIn
Dr. Fengbo Ren
Dr. Fengbo Ren

Founder & CEO

Fovus

LinkedIn
Sergio Ita, PhD
Sergio Ita, PhD

Senior Manager, Analytics

NueCell Bio

LinkedIn
Mark Marrano
Mark Marrano

Senior Director, Head of US Business Development, OXB

OXB

LinkedIn
Mitchell Sugii, MBA
Mitchell Sugii, MBA

Business Development Manager

CATUG

LinkedIn
Melis McHenry
Melis McHenry

Associate Director

Regeneron

LinkedIn
Arthur Sagoskin
Arthur Sagoskin

Chief Scientific Development Officer

MygoGenesis LLC

LinkedIn
Sagi Nahum
Sagi Nahum, Ph.D.

Global Senior Director – Analytical Sciences & QC, CGT

Orgenesis Inc

LinkedIn
Neil Templeton
Neil Templeton

Director, Upstream Process Development

Solid Biosciences

LinkedIn
Félix A. Montero-Julian
Félix A. Montero-Julian, PhD

VP Scientific Affairs

Accellix

LinkedIn

What to expect at the Cell & Gene Therapy Nexus 2026

  • Established Cell & Gene Therapies & Emerging Advancements
  • Novel & Emerging Modalities
  • Manufacturing, CMC & Analytics
  • AI & Digital Transformation in Cell and Gene Therapy

We are bringing together leading researchers, clinicians, biotech and pharma executives, solution providers, and investment leaders from across the global biopharmaceutical ecosystem. The event covers the full spectrum of the field, from foundational research and clinical translation to manufacturing, commercialization, and patient impact. With manufacturing involving living cells and complex gene delivery systems, the conference emphasizes the specialized facilities, logistics, and expertise required, while showcasing pioneering breakthroughs and strategies that are driving progress from cells to cures.

Join us to connect, collaborate, and contribute to the next wave of breakthroughs in cell and gene therapy, advancing the frontiers of biology and medical science. This is your opportunity to gain valuable insights, practical strategies, and meaningful industry connections.

  • Engage with Industry Leaders & Build Strategic Connections
  • Shape the Conversation
  • High-level plenaries with leading cell & gene therapy experts.
  • Interactive sessions exploring emerging technologies and innovative approaches in advanced therapies.
  • Targeted networking designed to foster collaborations and scientific partnerships
  • Connect with senior therapy leaders and solution providers in an exclusive, invitation-only setting.
  • Take home applicable frameworks and case studies to strengthen therapy development productivity.
  • Keep pace with emerging scientific, technological, and strategic trends shaping cell & gene therapy.

Our Partners

Our Invited Companies

Our Media Partners

Showcase Your Solutions at the BioPharma Cell & Gene Therapy Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative cell & gene therapy solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of advanced therapies and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real impact in the cell & gene therapy ecosystem.

Schedule At a Glance

08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
11:45 am - 12:05 am
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session & Drinks Reception
08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
11:45 am - 12:05 am
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Venue

Crowne Plaza San Diego Mission Valley

Name: Crowne Plaza San Diego Mission Valley

Address: 2270 Hotel Cir N, San Diego, CA 92108, United States

CONFERENCE REGISTRATION

Secure your spot today.